N1-(2-(6H-indolo[2,3-b]quinoxalin-6-yl)ethyl)-N3,N3-dimethylpropane-1,3-diamine

ID: ALA4071715

Chembl Id: CHEMBL4071715

PubChem CID: 137638545

Max Phase: Preclinical

Molecular Formula: C21H25N5

Molecular Weight: 347.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)CCCNCCn1c2ccccc2c2nc3ccccc3nc21

Standard InChI:  InChI=1S/C21H25N5/c1-25(2)14-7-12-22-13-15-26-19-11-6-3-8-16(19)20-21(26)24-18-10-5-4-9-17(18)23-20/h3-6,8-11,22H,7,12-15H2,1-2H3

Standard InChI Key:  GXPRLQGLDXJCBA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4071715

    ---

Associated Targets(non-human)

CV-1 (316 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vaccinia virus (4609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L929 (3802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Splenocyte (1641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vesicular stomatitis virus (4460 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.47Molecular Weight (Monoisotopic): 347.2110AlogP: 3.28#Rotatable Bonds: 7
Polar Surface Area: 45.98Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.13CX LogP: 3.11CX LogD: 0.00
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.52Np Likeness Score: -1.15

References

1. Klimenko K, Lyakhov S, Shibinskaya M, Karpenko A, Marcou G, Horvath D, Zenkova M, Goncharova E, Amirkhanov R, Krysko A, Andronati S, Levandovskiy I, Polishchuk P, Kuz'min V, Varnek A..  (2017)  Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents.,  27  (16): [PMID:28666733] [10.1016/j.bmcl.2017.06.035]

Source